Cyclosporine and itraconazole interaction in heart and lung transplant recipients.
Kramer
M R
MR
Stanford University Medical Center, California.
Marshall
S E
SE
Denning
D W
DW
Keogh
A M
AM
Tucker
R M
RM
Galgiani
J N
JN
Lewiston
N J
NJ
Stevens
D A
DA
Theodore
J
J
D001228:Aspergillosis / Q000188:drug therapy; D003048:Coccidiosis / Q000188:drug therapy; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007674:Kidney Diseases / Q000139:chemically induced*; D016040:Lung Transplantation; D013174:Sporotrichosis / Q000188:drug therapy
D003524:Cyclosporins; D017964:Itraconazole; D007654:Ketoconazole